Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

New Jersey joined 22 states suing the Trump administration to stop its plan to cut more than $11 billion in funding for ...

South Australian families will now have better protection against a potentially deadly respiratory virus, under a free state ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.3/100K) and ...

An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

If you haven’t gotten the flu shot, now may be the time. A record number of influenza cases has been reported in Australia, while Covid-19 and other respiratory illnesses are also circulating widely.

The risk for new-onset or recurrent AF was not increased among older adult patients with preexisting conditions following RSV vaccination.

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility was low in this cross-sectional study of hospitalized adults. Older adults and those with certain medical conditions ...